NovaBridge Biosciences American Depositary Shares
NBP
57 hedge funds and large institutions have $132M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 5 closing their positions.
320% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
36% more funds holding
Funds holding: 42 → 57 (+15)
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
18% more capital invested
Capital invested by funds: $112M → $132M (+$19.8M)
2.98% more ownership
Funds ownership: 25.82% → 28.8% (+3%)
23% less call options, than puts
Call options by funds: $277K | Put options by funds: $359K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.83M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$8.12M |
| 3 |
Morgan Stanley
New York
|
+$6.87M |
| 4 |
Millennium Management
New York
|
+$3.64M |
| 5 |
BlackRock
New York
|
+$2.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.3M |
| 2 |
EAM
Exome Asset Management
New York
|
-$4.16M |
| 3 |
SG Americas Securities
New York
|
-$1.89M |
| 4 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
-$1.51M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$529K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Daiwa Securities Group
Tokyo,
Japan
| $1K | +$1.53K | +346 | New |
|
|
VWM
52
Vermillion Wealth Management
Rosemount,
Minnesota
| $796 | +$885 | +200 | New |
|
|
SS
53
SBI Securities
Tokyo,
Japan
| $378 | +$398 | +90 | +1,800% |
|
54
RhumbLine Advisers
Boston,
Massachusetts
| $131 | – | – | – |
|
55
Osaic Holdings
Scottsdale,
Arizona
| $119 | – | – | – |
|
56
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $12 | +$13 | +3 | New |
|
|
ECSS
57
Eurizon Capital SGR SpA
Milan,
| $4 | +$4 | +1 | New |
|
|
SCM
58
Superstring Capital Management
New York
| – | -$529K | -139,886 | Closed |
|
|
LP
59
LMR Partners
London,
United Kingdom
| – | -$378K | -100,000 | Closed |
|
60
Renaissance Technologies
New York
| – | -$240K | -63,600 | Closed |
|
61
Aberdeen Group
Edinburgh,
United Kingdom
| – | -$165K | -43,738 | Closed |
|
62
Walleye Capital
New York
| – | -$41.6K | -11,000 | Closed |
|
NBP Hedge Fund Activity: Q4 2025 in Review
57 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2025, worth a combined $132M — up 18% from $112M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new NBP positions and 5 closed out — a net gain of 16 holders — while 16 added to existing stakes and 12 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $9.83M. The largest seller was Adage Capital Partners, cutting an estimated $10.3M.
- 57 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2025, up from 42 in Q3 2025.
- Funds reported $132M of NovaBridge Biosciences American Depositary Shares stock for Q4 2025, up 18% quarter-over-quarter.
- 21 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2025 and 5 closed out, a net change of +16 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2025 was Point72 Asset Management, an estimated $9.83M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2025 was Adage Capital Partners, an estimated $10.3M sold.
Based on aggregated 13F filings for Q4 2025.